Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 1/20 | 0.33 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | DHODH | Q02127 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | PTGES | O14684 | 1/20 | 0.31 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.30 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.30 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.30 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.30 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.30 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22858285 | 0.90 | PIK3CD (0.35) | TSPOPIK3CDDHODHPTGESPSEN1 | |
| SCHEMBL21718110 | 0.86 | PIK3CD (0.35) | TSPOAKR1B1PIK3CDDHODHPTGES | |
| SCHEMBL22679275 | 0.86 | TSPO (0.39) | TSPOMAOBRXRARXRBPTGES | |
| SCHEMBL22868338 | 0.85 | AKR1B1 (0.34) | TSPOAKR1B1PIK3CDDHODHPTGES | |
| SCHEMBL23029008 | 0.84 | CASR (0.35) | TSPO | |
| SCHEMBL21717832 | 0.83 | TSPO (0.39) | TSPOMAOBPTGESPSEN1PSEN2 | |
| SCHEMBL22858283 | 0.83 | TSPO (0.40) | TSPOMAOBRXRARXRBPTGES | |
| SCHEMBL21717382 | 0.83 | TSPO (0.40) | TSPOMAOBRXRARXRBPTGES | |
| SCHEMBL21710662 | 0.83 | NTSR1 (0.32) | TSPOPIK3CD | |
| SCHEMBL22858128 | 0.81 | RORA (0.37) | AKR1B1PSEN1PSEN2APH1BNCSTN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | TSPO 1263/4885AKR1B1 2451/4885MAOB 2771/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.